Company
FimmCyte
Towards Disease Modifying Treatments for Fibroinflammatory Diseases
Also known as FimmCyte AG
- Status
- Operatingas of 2026-09-18
- Headquarters
- Basel, Switzerland
- Legal name
- FimmCyte AG
Claim, correct or request removal
Record updated 18 September 2026
About
At FimmCyte, we are driven by the goal of leading innovation. Our most advanced endeavor is on developing targeted solutions to address endometriosis, a chronic disease that has been neglected for too long. Our first-in-class treatments, based on cutting-edge immunotherapy research, represent a disease-modifying approach going beyond traditional therapies.
Funding snapshot
- Latest round
- Convertible note2024-03-06
Funding rounds
- Convertible note
- 2024-03-06
Products
- Other
- FMC
Loading relationship preview